STOCK TITAN

UL Solutions (NYSE: ULS) director logs new dividend-equivalent stock units

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

UL Solutions Inc. director reports automatic stock-based accruals tied to deferred compensation. On December 8, 2025, the reporting person received 8 dividend equivalent rights and 4 dividend equivalent rights on existing deferred restricted stock units, both with an exercise price of $0.

Each dividend equivalent right represents a contingent right to receive one share of UL Solutions Class A common stock and accrues when dividends are paid on the stock. These rights vest proportionately with the underlying deferred restricted stock units, which either vested on May 1, 2025 or will vest on the earlier of May 20, 2026 or the next annual meeting, and are expected to be settled in shares under the company’s Non-Employee Director Deferred Compensation Plan.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Hooper Charles W

(Last) (First) (Middle)
C/O UL SOLUTIONS INC.
333 PFINGSTEN ROAD

(Street)
NORTHBROOK IL 60062

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
UL Solutions Inc. [ ULS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
12/08/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Deferred Restricted Stock Units (1) 12/08/2025 A 8(2) (3) (3) Class A Common Stock 8 $0 4,954(4) D
Deferred Restricted Stock Units (1) 12/08/2025 A 4(2) (5) (5) Class A Common Stock 4 $0 2,801(4) D
Explanation of Responses:
1. Each dividend equivalent right represents a contingent right to receive one share of the Issuer's Class A Common Stock.
2. Represents accrual of dividend equivalent rights on deferred restricted stock units held by the Reporting Person.
3. The dividend equivalent rights accrued on deferred restricted stock units held by the Reporting Person and vest proportionately with the deferred restricted stock units to which they relate. The deferred restricted stock units vested on May 1, 2025 and are expected to be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the reporting person pursuant to the Issuer's Non-Employee Director Deferred Compensation Plan (the "Plan"), or (ii) as otherwise provided by the Plan.
4. Includes deferred restricted stock units and all dividend equivalent rights that have accrued on such deferred restricted stock units to date.
5. The dividend equivalent rights accrued on deferred restricted stock units held by the Reporting Person and vest proportionately with the deferred restricted stock units to which they relate. The deferred restricted stock units will vest on the earlier of May 20, 2026 or the date of the annual meeting following the grant date and are expected to be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the reporting person pursuant to the Issuer's Plan, or (ii) as otherwise provided by the Plan.
/s/ Ryan Robinson, Attorney-in-Fact 12/10/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did UL Solutions (ULS) report in this Form 4?

The filing reports that a director of UL Solutions Inc. received additional dividend equivalent rights on existing deferred restricted stock units on December 8, 2025.

How many dividend equivalent rights were credited to the UL Solutions director?

The director was credited with 8 dividend equivalent rights and 4 dividend equivalent rights on deferred restricted stock units, each representing a contingent right to receive one share of Class A Common Stock.

Did the UL Solutions director pay anything for these dividend equivalent rights?

No. The derivative table shows an exercise price of $0 for both sets of dividend equivalent rights, reflecting that they are accruals tied to dividends, not purchases for cash.

When do the underlying deferred restricted stock units for the UL Solutions director vest?

One block of deferred restricted stock units vested on May 1, 2025, while another will vest on the earlier of May 20, 2026 or the date of the annual meeting following the grant date.

How and when are the UL Solutions dividend equivalent rights expected to be settled?

The dividend equivalent rights are expected to be settled in shares of UL Solutions Class A Common Stock either on a date selected by the director under the Non-Employee Director Deferred Compensation Plan or as otherwise provided by that plan.

Did this UL Solutions Form 4 disclose any sales of company stock by the director?

No sales are disclosed. The report covers accruals of dividend equivalent rights on existing deferred restricted stock units, not open-market purchases or sales of UL Solutions stock.
UL Solutions

NYSE:ULS

ULS Rankings

ULS Latest News

ULS Latest SEC Filings

ULS Stock Data

15.82B
61.90M
1.33%
109.13%
1.69%
Specialty Business Services
Services-testing Laboratories
Link
United States
NORTHBROOK